---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-017575"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2025-10-09T23:59:59+00:00"
generated_at: "2026-05-17T04:10:34.380465+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# SRx Health stockholders approve 25x share increase and up to 85:1 reverse split

## Summary
- Authorized shares increased from 200M to 5B; additional reverse split range 15:1 to 85:1 approved.
- Issuance above 19.99% outstanding authorized under ELOC Purchase Agreement and July 2025 SPA.
- Bylaw quorum lowered from majority to one-third of outstanding shares.
- Written consent holders with 51.20% voting power approved all matters; no opposition.
- Additional reverse split must occur by March 31, 2026 at Board's discretion.

## SEC filing metadata
- accession: 0001493152-25-017575
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2025-10-09T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315225017575/0001493152-25-017575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315225017575/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-017575
- JSON: https://secwatch.observer/filing/0001493152-25-017575.json
- Plain text: https://secwatch.observer/filing/0001493152-25-017575.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.